SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
123 hedge funds and large institutions have $1.93B invested in Sage Therapeutics in 2015 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 53 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
34% more funds holding
Funds holding: 92 → 123 (+31)
68% less call options, than puts
Call options by funds: $3.23M | Put options by funds: $10.2M
Holders
123
Holding in Top 10
5
Calls
$3.23M
Puts
$10.2M
Top Buyers
| 1 | +$67.8M | |
| 2 | +$66.2M | |
| 3 | +$55.4M | |
| 4 |
VAM
Visium Asset Management
New York
|
+$46.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$29.7M |
Top Sellers
| 1 | -$73M | |
| 2 | -$21.2M | |
| 3 | -$19.2M | |
| 4 |
Millennium Management
New York
|
-$10.1M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$8.13M |